These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 27965013)

  • 1. Patient comprehension and attitudes toward maintenance chemotherapy for lung cancer.
    Gerber DE; Hamann HA; Rasco DW; Woodruff S; Lee SJ
    Patient Educ Couns; 2012 Oct; 89(1):102-8. PubMed ID: 22632736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unrealistic expectations and disclosure of incurability in patients with non-small cell lung cancer.
    Hasegawa T; Okuyama T; Uemura T; Matsuda Y; Otani H; Shimizu J; Horio Y; Watanabe N; Yamaguchi T; Fukuda S; Oguri T; Maeno K; Inagaki Y; Nosaki K; Fukumitsu K; Akechi T
    Support Care Cancer; 2024 Jun; 32(7):421. PubMed ID: 38856947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A survey of Italian physicians' opinion about stem cells research: what doctors prefer and what the law requires.
    Frati P; Gulino M; Pacchiarotti A; D'Errico S; Sicuro L; Fineschi V
    Biomed Res Int; 2014; 2014():480304. PubMed ID: 24877099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of cancer patients' utilization of psychooncological support: Examining patient´s attitude and physician´s recommendation.
    Goerling U; Albus C; Bergelt C; Erim Y; Faller H; Geiser F; Hönig K; Hornemann B; Maatouk I; Stein B; Teufel M; Wickert M; Weis J
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):17997-18004. PubMed ID: 37978060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II Trial of Dose-dense Pemetrexed, Gemcitabine, and Bevacizumab in Patients With Advanced, Non-Small-cell Lung Cancer.
    Schneider BJ; Kalemkerian GP; Gadgeel SM; Valdivieso M; Hackstock DM; Chen W; Heilbrun LK; Ruckdeschel JC; Wozniak AJ
    Clin Lung Cancer; 2017 May; 18(3):299-302. PubMed ID: 28063799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antineoplastic Treatment of Advanced-Stage Non-Small-Cell Lung Cancer: Treatment, Survival, and Spending (2000 to 2011).
    Bradley CJ; Yabroff KR; Mariotto AB; Zeruto C; Tran Q; Warren JL
    J Clin Oncol; 2017 Feb; 35(5):529-535. PubMed ID: 28045621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bevacizumab Plus Pemetrexed Versus Pemetrexed Alone as Maintenance Therapy for Patients With Advanced Nonsquamous Non-Small-cell Lung Cancer: Update From the Swiss Group for Clinical Cancer Research (SAKK) 19/09 Trial.
    Gautschi O; Rothschild SI; Li Q; Matter-Walstra K; Zippelius A; Betticher DC; Früh M; Stahel RA; Cathomas R; Rauch D; Pless M; Peters S; Froesch P; Zander T; Schneider M; Biaggi C; Mach N; Ochsenbein AF;
    Clin Lung Cancer; 2017 May; 18(3):303-309. PubMed ID: 27993482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in Lung Cancer Treatment Preferences Among Oncologists, Patients and Family Members: A Semi-Structured Qualitative Study in China.
    He X; Zhang M; Wu J; Xu S; Jiang X; Wang Z; Zhang S; Xie F
    Patient Prefer Adherence; 2021; 15():775-783. PubMed ID: 33883885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life in patients with advanced non-small-cell lung cancer given maintenance treatment with pemetrexed versus placebo (H3E-MC-JMEN): results from a randomised, double-blind, phase 3 study.
    Belani CP; Brodowicz T; Ciuleanu TE; Krzakowski M; Yang SH; Franke F; Cucevic B; Madhavan J; Santoro A; Ramlau R; Liepa AM; Visseren-Grul C; Peterson P; John WJ; Zielinski CC
    Lancet Oncol; 2012 Mar; 13(3):292-9. PubMed ID: 22336221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Maintenance therapy for advanced non-small-cell lung cancer].
    Saruwatari K; Yoh K
    Gan To Kagaku Ryoho; 2014 Aug; 41(8):926-31. PubMed ID: 25132023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pemetrexed use in the adjuvant setting for completely resectable non-small-cell lung cancer.
    Simon GR; Manegold C; Barker SS; Treat JA; Visseren-Grul C; Obasaju C
    Clin Lung Cancer; 2013 Nov; 14(6):601-8. PubMed ID: 23921171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients' Attitudes and Physicians' Perceptions Toward Maintenance Therapy for Advanced Non-Small-cell Lung Cancer: A Multicenter Italian Survey.
    Pacchiana MV; Capelletto E; Carnio S; Gridelli C; Rossi A; Galetta D; Montagna ES; Bordi P; Ceribelli A; Cortinovis D; Scotti V; Martelli O; Valmadre G; Del Conte A; Miccianza A; Morena R; Rosetti F; Di Maio M; Ostacoli L; Novello S
    Clin Lung Cancer; 2017 Jul; 18(4):381-387. PubMed ID: 27965013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical decision-making and health-related quality of life during first-line and maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC): findings from a real-world setting.
    Sztankay M; Giesinger JM; Zabernigg A; Krempler E; Pall G; Hilbe W; Burghuber O; Hochmair M; Rumpold G; Doering S; Holzner B
    BMC Cancer; 2017 Aug; 17(1):565. PubMed ID: 28835219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance therapy for advanced non-small-cell lung cancer: a pilot study on patients' perceptions.
    Peeters L; Sibille A; Anrys B; Oyen C; Dooms C; Nackaerts K; Wauters I; Vansteenkiste J
    J Thorac Oncol; 2012 Aug; 7(8):1291-5. PubMed ID: 22659963
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.